Bupropion for the Treatment of Methamphetamine Dependence - 1

Phase 2 Completed 150 enrolled National Institute on Drug Abuse (NIDA)

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence

Timeline

Start: 2003-07
Primary completion: —
Completion: 2005-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bupropion	Small molecule	—	—

Bupropion for the Treatment of Methamphetamine Dependence - 1

Summary

Timeline

Drugs

Indications